News
-
realize the new crown antigen in our province. “Breakthrough” in detection reagents
At the registration pre-examination counseling meeting, the participating experts carefully understood the preparation of Hongda Company’s registration application. After reviewing the registration application materials, they put forward constructive commRead more -
in vitro diagnostic reagent new crown antigen detection kit
On May 16, the provincial bureau held a special meeting to conduct product registration pre-examination guidance for the third-type in vitro diagnostic reagent new crown antigen detection kit (colloidal gold method) applied for by Jiangxi Hongda Medical DRead more -
the South Korean government required all people entering the country
On May 23, the Central Epidemic Prevention and Control Headquarters of South Korea notified that as of 0:00 that day, South Korea had added 9,975 new confirmed cases of new coronary pneumonia within 24 hours, with a total of 17,967,672 confirmed cases. ThRead more -
3CL protease inhibitor RAY1216 tablets was approved by the Ethics Committee of the First Hospital of Jilin University
Beijing News On May 22, Zhongsheng Pharmaceutical issued an announcement that the Phase I clinical trial plan of Zhongsheng Ruichuang oral anti-new coronavirus 3CL protease inhibitor RAY1216 tablets was approved by the Ethics Committee of the First HospiRead more -
requirements for the development of a new crown vaccine
In March 2022, the World Health Organization issued an interim statement, which set out higher expectations and requirements for the development of a new crown vaccine – that is, ideally, a new crown vaccine should not only prevent serious illness and deaRead more -
the IgA level of the new crown vaccine
The immunogenicity results showed that after 28 days of sequential booster immunization with CanSino inhaled new crown vaccine, the neutralizing antibody levels against the original strain in the two dose groups were 18.4-26.4 times that of the inactivateRead more -
the media reported that the future vaccine “inoculation” process may be more like drinking coffee
Previously, the media reported that the future vaccine “inoculation” process may be more like drinking coffee. “One cup per person, take a cup of nebulized vaccine in front of the nebulizer that resembles a coffee machine, take a deep breath, hold for 5 sRead more -
the new coronavirus has continued to mutate and is still ravaging the world
Through the clinical trial of 420 subjects, the sequential strengthening, which is also known as the “mixed fight” CanSino inhalation by the public, has good safety, and the total adverse reaction rate is lower than that of the inactivated vaccine homologRead more -
consino biological inhalation with adenovirus vector new crown vaccine kwatha
On May 20, Consino Biotechnology published a research paper in The Lancet Respiratory Medicine, according to its official wechat account on Wednesday.Studies show that consino biological inhalation with adenovirus vector new crown vaccine kwatha (hereinafRead more -
The official website published an article on 22
The United Nations official website published an article on the 22nd that the Director-General of the World Health Organization Tedros Adhanom Ghebreyesus said at the opening ceremony of the 75th World Health Assembly on the 22nd that currently only 57 coRead more -
the similar microthrombosis observed in patients with severe and prolonged COVID-19.
Previous research has suggested that the spike protein may be involved in the creation of small blood clots. Blood contains fibrin, which helps blood clot when blood vessels are damaged. As the wound begins to heal, the clot should be broken down by plasmRead more -
the human immune system can affect the spike protein on the surface of the new coronavirus
Researchers at Linköping University in Sweden have found that the human immune system can affect the spike protein on the surface of the new coronavirus, resulting in a misfolded spike protein called amyloid. There may be a link between harmful amyloid prRead more